Catalyst Wire Dossier Catalyst Wire Dossier

MYQORZO

aficamten · Cytokinetics Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MYQORZO, covering 2025-12-19 to 2026-04-16. Get the full timeline:

Most recent: EMA Authorised: Myqorzo (aficamten) — Cytokinetics (Ireland) Limited

See pricing